The War Goes On

The Science Business Blog at Forbes looks into what it dubs the “gene machine wars.” There, Matthew Herper points out that just weeks after Illumina announced that its HiSeq 2000 could sequence a human genome for about $10,000, that Life Technologies said its SOLiD 4 that could do it for $6,000. Herper says that Illumina won’t lose its place at the top.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.